Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3028% below fair value
$3.31+0.24 (+7.82%)
Close on Nov 12, 2026Market cap $35.95MP/E 18.4Yield –
Nephros operating margin
Operating margin is operating income as a percentage of revenue.
Nephros's operating margin for the twelve months ending Sep 30, 2026 was 8.5%. For fiscal 2025 it was 6.1%, against 0.0% the year before. The highest annual figure on record is 6.1% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.1% | +6.1 |
| FY2024 | Dec 31, 2024 | 0.0% | +11.2 |
| FY2023 | Dec 31, 2023 | -11.2% | +32.3 |
| FY2022 | Dec 31, 2022 | -43.5% | −11.6 |
| FY2021 | Dec 31, 2021 | -31.8% | +18.1 |
| FY2020 | Dec 31, 2020 | -49.9% | −19.4 |
| FY2019 | Dec 31, 2019 | -30.5% | +22.5 |
| FY2018 | Dec 31, 2018 | -53.0% | +5.4 |
| FY2017 | Dec 31, 2017 | -58.4% | +65.2 |
| FY2016 | Dec 31, 2016 | -123.7% | +52.3 |
| FY2015 | Dec 31, 2015 | -176.0% | −23.3 |
| FY2014 | Dec 31, 2014 | -152.7% | +37.9 |
| FY2013 | Dec 31, 2013 | -190.6% | −6.2 |
| FY2012 | Dec 31, 2012 | -184.4% | −80.1 |
| FY2011 | Dec 31, 2011 | -104.3% | −40.0 |
| FY2010 | Dec 31, 2010 | -64.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 8.9% | +2.3 |
| Q2 FY2026 | Jun 30, 2026 | 20.2% | +14.5 |
| Q1 FY2026 | Mar 31, 2026 | 1.9% | −9.7 |
| Q4 FY2025 | Dec 31, 2025 | 0.4% | −7.8 |
| Q3 FY2025 | Sep 30, 2025 | 6.6% | +0.7 |
| Q2 FY2025 | Jun 30, 2025 | 5.6% | +15.4 |
| Q1 FY2025 | Mar 31, 2025 | 11.6% | +17.3 |
| Q4 FY2024 | Dec 31, 2024 | 8.2% | +28.1 |
| Q3 FY2024 | Sep 30, 2024 | 5.9% | +11.3 |
| Q2 FY2024 | Jun 30, 2024 | -9.7% | +2.5 |
| Q1 FY2024 | Mar 31, 2024 | -5.7% | +2.6 |
| Q4 FY2023 | Dec 31, 2023 | -19.9% | +7.1 |
| Q3 FY2023 | Sep 30, 2023 | -5.4% | +47.8 |
| Q2 FY2023 | Jun 30, 2023 | -12.3% | +16.3 |
| Q1 FY2023 | Mar 31, 2023 | -8.3% | +63.4 |
| Q4 FY2022 | Dec 31, 2022 | -27.1% | −0.5 |
| Q3 FY2022 | Sep 30, 2022 | -53.2% | −22.1 |
| Q2 FY2022 | Jun 30, 2022 | -28.6% | +20.7 |
| Q1 FY2022 | Mar 31, 2022 | -71.7% | −34.4 |
| Q4 FY2021 | Dec 31, 2021 | -26.6% | +4.2 |
| Q3 FY2021 | Sep 30, 2021 | -31.1% | +12.8 |
| Q2 FY2021 | Jun 30, 2021 | -49.3% | +52.0 |
| Q1 FY2021 | Mar 31, 2021 | -37.2% | +3.4 |
| Q4 FY2020 | Dec 31, 2020 | -30.8% | −21.6 |
| Q3 FY2020 | Sep 30, 2020 | -43.9% | −21.5 |
| Q2 FY2020 | Jun 30, 2020 | -101.3% | −63.7 |
| Q1 FY2020 | Mar 31, 2020 | -40.6% | +33.0 |
| Q4 FY2019 | Dec 31, 2019 | -9.2% | +36.0 |
| Q3 FY2019 | Sep 30, 2019 | -22.5% | +7.2 |
| Q2 FY2019 | Jun 30, 2019 | -37.6% | +10.2 |
| Q1 FY2019 | Mar 31, 2019 | -73.5% | +40.5 |
| Q4 FY2018 | Dec 31, 2018 | -45.2% | −14.2 |
| Q3 FY2018 | Sep 30, 2018 | -29.6% | +26.9 |
| Q2 FY2018 | Jun 30, 2018 | -47.8% | +33.7 |
| Q1 FY2018 | Mar 31, 2018 | -114.0% | −31.6 |
| Q4 FY2017 | Dec 31, 2017 | -31.0% | +50.7 |
| Q3 FY2017 | Sep 30, 2017 | -56.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -81.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -82.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -81.7% | – |
See a number that looks wrong?